- Home
- PDM vs YDES Comparison
PDM vs YDES Comparison
Compare PDM & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDM | YDES |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Building operators | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 894.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PDM | YDES |
|---|---|---|
| Price | $8.38 | $11.97 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 585.8K | 62.4K |
| Earning Date | 02-11-2026 | 09-30-2025 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $565,372,000.00 | $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.76 |
| 52 Week Low | $5.46 | $5.30 |
| 52 Week High | $9.19 | $31.00 |
Technical Indicators
Market Signals| Indicator | PDM | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | N/A |
| Support Level | $8.23 | N/A |
| Resistance Level | $8.57 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 39.68 | 0.00 |
Price Performance
Historical ComparisonAbout PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.